BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9482700)

  • 1. Eosinophil granulocyte interaction with serum-opsonized particles: binding and degranulation are enhanced by tumor necrosis factor alpha.
    Egesten A; Blom M; Calafat J; Janssen H; Knol EF
    Int Arch Allergy Immunol; 1998 Feb; 115(2):121-8. PubMed ID: 9482700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophil leukocyte degranulation in response to serum-opsonized beads: C5a and platelet-activating factor enhance ECP release, with roles for protein kinases A and C.
    Egesten A; Malm J
    Allergy; 1998 Nov; 53(11):1066-73. PubMed ID: 9860239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the release of eosinophil cationic protein by eosinophil adhesion.
    Xu X; HÃ¥kansson L
    Clin Exp Allergy; 2000 Jun; 30(6):794-806. PubMed ID: 10848898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phorbol ester-induced degranulation in adherent human eosinophil granulocytes is dependent on CD11/CD18 leukocyte integrins.
    Egesten A; Gullberg U; Olsson I; Richter J
    J Leukoc Biol; 1993 Mar; 53(3):287-93. PubMed ID: 8095965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of IL-3, IL-5, and GM-CSF on normal human eosinophil and neutrophil C3b-induced degranulation.
    Carlson M; Peterson C; Venge P
    Allergy; 1993 Aug; 48(6):437-42. PubMed ID: 8238799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of PAF, FMLP and opsonized zymosan on the release of ECP, elastase and superoxide from human granulocytes.
    Turner NC; Wood LJ; Foster M; Gueremy T
    Eur Respir J; 1994 May; 7(5):934-40. PubMed ID: 8050551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of rapamycin, cyclosporin A, and dexamethasone on interleukin 5-induced eosinophil degranulation and prolonged survival.
    Meng Q; Ying S; Corrigan CJ; Wakelin M; Assoufi B; Moqbel R; Kay AB
    Allergy; 1997 Nov; 52(11):1095-101. PubMed ID: 9404561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of human lung fibroblasts on eosinophil degranulation.
    Takafuji S; Miyakuni Y; Nakagawa T; Shoji S; Murata S; Yamamoto K; Ito K
    Allergy; 2000 Dec; 55(12):1170-8. PubMed ID: 11117275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophil degranulation in the presence of bronchial epithelial cells. Effect of cytokines and role of adhesion.
    Takafuji S; Ohtoshi T; Takizawa H; Tadokoro K; Ito K
    J Immunol; 1996 May; 156(10):3980-5. PubMed ID: 8621939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophil chemiluminescence response to cytokines and opsonized zymosans in atopic dermatitis.
    Miyasato M; Taguchi K; Tsuda S; Kitamura N; Kato K
    Int Arch Allergy Immunol; 1994; 104 Suppl 1(1):24-6. PubMed ID: 8155999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of lymphocyte proliferation by eosinophils via chymotrypsin-like protease activity and adhesion molecule interaction.
    Matsunaga Y; Shono M; Takahashi M; Tsuboi Y; Ogawa K; Yamada T
    Br J Pharmacol; 2000 Aug; 130(7):1539-46. PubMed ID: 10928955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophils maintain their capacity to signal and release eosinophil cationic protein upon repetitive stimulation with the same agonist.
    Simon HU; Weber M; Becker E; Zilberman Y; Blaser K; Levi-Schaffer F
    J Immunol; 2000 Oct; 165(7):4069-75. PubMed ID: 11034418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degranulation from human eosinophils stimulated with C3a and C5a.
    Takafuji S; Tadokoro K; Ito K; Dahinden CA
    Int Arch Allergy Immunol; 1994; 104 Suppl 1(1):27-9. PubMed ID: 8156000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel thromboxane synthetase inhibitor, DP-1904, inhibits human blood eosinophil degranulation.
    Agrawal DK; Takami M; Ono S
    Inflammation; 1997 Feb; 21(1):1-8. PubMed ID: 9179617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophil degranulation in the presence of lung fibroblasts.
    Takafuji S; Shoji S; Ito K; Yamamoto K; Nakagawa T
    Int Arch Allergy Immunol; 1998 Sep; 117 Suppl 1():52-4. PubMed ID: 9758898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of interleukin (IL)-3 and IL-5 on human eosinophil degranulation induced by complement components C3a and C5a.
    Takafuji S; Tadokoro K; Ito K
    Allergy; 1996 Aug; 51(8):563-8. PubMed ID: 8874660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory syncytial virus-infected pulmonary epithelial cells induce eosinophil degranulation by a CD18-mediated mechanism.
    Olszewska-Pazdrak B; Pazdrak K; Ogra PL; Garofalo RP
    J Immunol; 1998 May; 160(10):4889-95. PubMed ID: 9590236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intercellular adhesion molecule-1 on eosinophils is involved in eosinophil protein X release induced by cytokines.
    Horie S; Okubo Y; Hossain M; Momose T; Suzuki J; Isobe M; Sekiguchi M
    Immunology; 1997 Feb; 90(2):301-7. PubMed ID: 9135561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms for eosinophil degranulation; release of the eosinophil cationic protein.
    Winqvist I; Olofsson T; Olsson I
    Immunology; 1984 Jan; 51(1):1-8. PubMed ID: 6317543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of granule proteins from human eosinophils stimulated with mast-cell mediators.
    Takafuji S; Tadokoro K; Ito K; Nakagawa T
    Allergy; 1998 Oct; 53(10):951-6. PubMed ID: 9821474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.